• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Emad Rizk, MD, president, McKesson Health Solutions


Emad Rizk, MD, has devoted his energies to developing a disease management model that extends beyond telephonic communications to an on-the-ground, comprehensive model.

Emad Rizk, MD
President, McKesson Health Solutions
Denver, Colo.

Dr. Rizk believes this new "DM" emphasizes more comprehensive care management, consistent alignment between payer and providers with metrics and incentives.

In 2008, Modern Physician named Dr. Rizk as one of the nation's "50 Most Powerful Physician Executives." He serves on the DMAA board of directors and is a past vice-chairman of the National Clinical Advisory Board. In addition, he has published articles on a variety of healthcare topics.

Prior to joining McKesson, Dr. Rizk served as the lead partner and global director, medical management/pharmacy for Deloitte Consulting nationally.

Related Content
© 2024 MJH Life Sciences

All rights reserved.